7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Myositis, Inclusion Body D018979 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hearing Loss D034381 3 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
beta-Thalassemia D017086 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Radicular Cyst D011842 2 associated lipids
Ankylosis D000844 1 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Jaw Diseases D007571 4 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Hypercalciuria D053565 4 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Dengue D003715 2 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Malnutrition D044342 6 associated lipids
Insulin Resistance D007333 99 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Hot Flashes D019584 5 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Vascular Calcification D061205 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetes Complications D048909 4 associated lipids
Pericardial Effusion D010490 2 associated lipids
Emphysema D004646 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Atrial Remodeling D064752 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Lithiasis D020347 2 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Thomas RJ et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. 1999 Endocrinology pmid:10499498
Itonaga I et al. 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. 1999 Biochem. Biophys. Res. Commun. pmid:10529407
Nakagawa N et al. Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. 1999 Biochem. Biophys. Res. Commun. pmid:10548488
Nakagawa N et al. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. 1999 Biochem. Biophys. Res. Commun. pmid:10548507
Kong YY et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. 1999 Nature pmid:10580503
Yamashita T et al. Retardation in bone resorption after bone marrow ablation in klotho mutant mice. 2000 Endocrinology pmid:10614667
Itonaga I et al. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. 2000 Ann. Rheum. Dis. pmid:10627423
Chikatsu N et al. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. 2000 Biochem. Biophys. Res. Commun. pmid:10631114
Hofbauer LC et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. 2000 J. Bone Miner. Res. pmid:10646108
Tricot G New insights into role of microenvironment in multiple myeloma. 2000 Lancet pmid:10675068
Makhluf HA et al. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. 2000 Biochem. Biophys. Res. Commun. pmid:10679262
Merewether LA et al. Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. 2000 Arch. Biochem. Biophys. pmid:10683254
Takayanagi H et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. 2000 Arthritis Rheum. pmid:10693864
Huang L et al. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. 2000 Am. J. Pathol. pmid:10702390
Capparelli C et al. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. 2000 Cancer Res. pmid:10706080
Ross FP RANKing the importance of measles virus in Paget's disease. 2000 J. Clin. Invest. pmid:10712423
Bateman TA et al. Osteoprotegerin mitigates tail suspension-induced osteopenia. 2000 Bone pmid:10773583
Mukohyama H et al. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. 2000 Biochem. Biophys. Res. Commun. pmid:10777696
Atkins GJ et al. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. 2000 J. Bone Miner. Res. pmid:10780856
Aubin JE and Bonnelye E Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. 2000 Medscape Womens Health pmid:10792853

Table of Content